Navigation Links
BELLUS HEALTH reports results for first quarter of fiscal 2008
Date:5/5/2008

ompany believes that expectations represented by forward-looking statements are reasonable, yet there can be no assurance that such expectations will prove to be correct. Unless otherwise stated, the forward-looking statements contained in this report are made as of the date of this report, and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, unless required by applicable legislation or regulation. The forward-looking statements contained in this report are expressly qualified by this cautionary statement.

BELLUS Health Inc.

Consolidated Financial Information (1)

(in thousands of US dollars, except per share data)

Three-month period ended

March 31

-------------------------------------------------------------------------

Consolidated Statements of Operations 2008 2007

-------------------------------------------------------------------------

-------------------------------------------------------------------------

(unaudited) (unaudited)

Revenues:

Collaboration agreement $205 $373

Reimbursable costs 22 128

-------------------------------------------------------------------------

227 501

-------------------------------------------------------------------------

Expenses :

Research and development 8,780 16,828

Research tax credits and grants (397) (506)

--------------------------------------------------------
'/>"/>

SOURCE BELLUS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. More proof needed of safety and quality of electronic personal health records
6. Health care incentive model offers collaborative approach
7. Loneliness is bad for your health
8. Mailman School of Public Health study examines link between racial discrimination and substance use
9. Green Tea May Brew Up Healthier Skin
10. For Health Info, Women Often Turn to the Web
11. Record Number of Americans Lack Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...the U.S. Food and Drug Administration Drug has qui...omplex nature of diseases for which new therapeuti...ical development times, according to the Tufts Cen...rage time for the FDA to approve new drugs decline...verage clinical phase time means combined clinical...
(Date:1/8/2009)...Medical Center (URMC) has received a U.S. patent f...curately screen for organisms such as bacteria and...LLC, a Rochester-based life sciences company, is t...ology. , The company,s technology platform cal...genetic sequences from biological samples, a proce...
(Date:1/8/2009)...ingCedarsofRussia.org released research this month...n Cedar nuts, also known as Pinus Sibirica, has be... trial conducted by Professor A. B. Krivosheev fro...th wild harvested, cold pressed, extra virgin Sibe...nd. Pine nut oil was proven effective against the ...
(Date:1/8/2009)...8 The flu season will likely hit,...from the national Centers,for Disease Control and...ts,and teachers to take action to help reduce the...n the battle against the spread of germs, particul...tly attending or working at a school(1). , ...
Breaking Medicine News(10 mins):Health News:New drug development still takes 8 years despite faster FDA review, according to Tufts CSDD 2Health News:URMC, Lighthouse Biosciences awarded US patent for diagnostic technology 2Health News:RingingCedarsofRussia.org Releases Pine Nut Oil Research Showing That Digestive and Stomach Disorders Respond to Unique Super Food: Siberian Pine Nut Oil 2Health News:Clorox Partners With PTA to Help Parents and Teachers Prepare for Height of Flu Season 2Health News:Clorox Partners With PTA to Help Parents and Teachers Prepare for Height of Flu Season 3Health News:Clorox Partners With PTA to Help Parents and Teachers Prepare for Height of Flu Season 4
...ll disease is a genetic disease that occurs predom...fer from severe attacks of pain from blood vessels...igid and form a sickle shape when de-oxygenated. H...nary hypertension. Specialists say it has nothing ...
...apy works by inserting modified genes to treat an ...de harmless to humans. But injecting these gene-ca...n a problem, because most of the virus ends up in ...bodies and washes them out of the blood.// That ma...
...rch presented at the annual meeting of the Radiolo...graphy scans may accurately detect small cancers a...cts of high-risk patients.// Multi Detector CT Ur... using helical CT scanners, which pass X-rays thro...
...latest wrinkle in research toward finding a pill t...from exposure to loud noise. While the effort is h...ust the past few years.// Starting in a few months... training with not only foam plugs in their ears, ...
Other Medicine News:Health News:Reducing The Risk Of Death In Sickle Cell Disease 2Health News:CT Scans Said to Accurately Detect Small Cancers 2Health News:Pill might be able to reduce the damage loud noise does to your hearing 2Health News:Pill might be able to reduce the damage loud noise does to your hearing 3
(Date:1/7/2009)..., Late Preterm Infants Drive the Increase , , ... -- New government statistics confirm that the dec...rate continues, putting more infants than ever at ...o the March of Dimes. , , Nearly 543,000 babies...onal Center for Health Statistics, which today rel...
(Date:1/7/2009)..., OXFORD, England, January 7 ...any focused on allergy and critical care, today,a...s achieved in 2008 with,its ToleroMune(R) anti-al...atient recruitment for a further phase II clinical...ay in Canada, has recruited 120 patients with conf...
(Date:1/6/2009)..., NEW YORK, Jan. 6 The...t $2.7 million to four industry research teams for... for Parkinson,s disease. , , The funding was a...pment Initiative. This program, first launched in...rts on Parkinson,s research. TDI is part of MJFF...
(Date:1/6/2009)..., PARIS, France, January 6 /PRNewswire-FirstC...to Extend the Collaboration Until,December 2011 ,...ion to Include Antibody,Discovery in Ophthalmolog... to ExonHit if Allergan,Sublicenses to a Third Pa...EHT) today announced a reinforcement,of its exist...
Breaking Medicine Technology:Preterm Births Rise 36 Percent Since Early 1980s 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4New book examines disability in Islamic law 8115 1Global climate change 3A The impact of El Ni 26 23241 3Bo on Gal 26 23225 3Bpagos marine iguanas 1556 1Global climate change 3A The impact of El Ni 26 23241 3Bo on Gal 26 23225 3Bpagos marine iguanas 1556 2Francks Compounding Lab Purchases Wisconsin Pharmacy 8113 1Generic Prescription Drugs Show Increasingly Greater Use in Southeastern Pennsylvania 8110 1Generic Prescription Drugs Show Increasingly Greater Use in Southeastern Pennsylvania 8110 2Generic Prescription Drugs Show Increasingly Greater Use in Southeastern Pennsylvania 8110 3Generic Prescription Drugs Show Increasingly Greater Use in Southeastern Pennsylvania 8110 4
...-Mar 7, 2007 - BioLineRx Ltd.,(TASE:BLRX), Israel,... pre-clinical data from trials of BL-1040 demonstr...rioration of the myocardium,after a myocardial inf...tation and eventual heart failure in a pig model. ...ld Cardiac Research,Institute at Sheba Medical Cen...
...III trial data underlines M6G,s,benefit compared t... , CAMBRIDGE, England, 7th March 2007 - CeNeS Phar...opharmaceutical company today,announces additional... M6G (morphine-6-glucuronide) in over 500 patients...leased on 20th February,showed that M6G provided e...
Other Medicine Technology:BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 2BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 3CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 2CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 3CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 4CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 5CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 6CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 7
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: